These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23063074)

  • 41. Host responses to the human microbiome.
    Bäckhed F
    Nutr Rev; 2012 Aug; 70 Suppl 1():S14-7. PubMed ID: 22861802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut.
    Suzuki K; Ha SA; Tsuji M; Fagarasan S
    Semin Immunol; 2007 Apr; 19(2):127-35. PubMed ID: 17161619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospects for systems biology and modeling of the gut microbiome.
    Karlsson FH; Nookaew I; Petranovic D; Nielsen J
    Trends Biotechnol; 2011 Jun; 29(6):251-8. PubMed ID: 21392838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of microbial colonization of the gut in early life to the development of immunity.
    Kelly D; King T; Aminov R
    Mutat Res; 2007 Sep; 622(1-2):58-69. PubMed ID: 17612575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of metabolism: a cross talk between gut microbiota and its human host.
    Burcelin R
    Physiology (Bethesda); 2012 Oct; 27(5):300-7. PubMed ID: 23026753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut-microbiota interactions in non-mammals: what can we learn from Drosophila?
    Charroux B; Royet J
    Semin Immunol; 2012 Feb; 24(1):17-24. PubMed ID: 22284578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal microbiota and the immune system in metabolic diseases.
    Sittipo P; Lobionda S; Lee YK; Maynard CL
    J Microbiol; 2018 Mar; 56(3):154-162. PubMed ID: 29492872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
    Damman CJ; Miller SI; Surawicz CM; Zisman TL
    Am J Gastroenterol; 2012 Oct; 107(10):1452-9. PubMed ID: 23034604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic endotoxaemia: is it more than just a gut feeling?
    Piya MK; Harte AL; McTernan PG
    Curr Opin Lipidol; 2013 Feb; 24(1):78-85. PubMed ID: 23298961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How the interplay between antigen presenting cells and microbiota tunes host immune responses in the gut.
    Swiatczak B; Rescigno M
    Semin Immunol; 2012 Feb; 24(1):43-9. PubMed ID: 22137188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation.
    Laugerette F; Vors C; Peretti N; Michalski MC
    Biochimie; 2011 Jan; 93(1):39-45. PubMed ID: 20433893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):265-70. PubMed ID: 23743644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Friendly pathogens: prevent or provoke autoimmunity.
    Sathyabama S; Khan N; Agrewala JN
    Crit Rev Microbiol; 2014 Aug; 40(3):273-80. PubMed ID: 23688247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.
    Holmes E; Li JV; Marchesi JR; Nicholson JK
    Cell Metab; 2012 Nov; 16(5):559-64. PubMed ID: 23140640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The human gastrointestinal microbiota--an unexplored frontier for pharmaceutical discovery.
    Roeselers G; Bouwman J; Venema K; Montijn R
    Pharmacol Res; 2012 Dec; 66(6):443-7. PubMed ID: 23000437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune system and gut flora interactions are important episodes in metabolic diseases.
    Jain S; Marotta F; Catanzaro R; Yadav H
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):347-8. PubMed ID: 23256115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.